FDA Advisory Panel Votes Against Drug Combination Phentermine / Topiramate for Weight Loss

GAITHERSBURG, Md. — A Food and Drug Administration advisory panel voted 10 to 6 against recommending approval of a combination of phentermine and topiramate as a weight loss agent because of concerns over the treatment’s risk-benefit profile.